Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
M.D. Anderson Cancer Center
University of Florida
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
University of Michigan Rogel Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Children's Oncology Group
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
University of Illinois at Chicago
City of Hope Medical Center
Fred Hutchinson Cancer Center
Medical College of Wisconsin
City of Hope Medical Center
Shenzhen TargetRx Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
Ascentage Pharma Group Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Memorial Sloan Kettering Cancer Center
Nanfang Hospital, Southern Medical University
Roswell Park Cancer Institute
Rutgers, The State University of New Jersey
Northwestern University
Incyte Corporation
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Takeda
Fred Hutchinson Cancer Center